Three-year data from the Phase Ib trial of BOT+BAL was unveiled at ESMO GI 2026.
A new study suggests GLP-1 medications, such as semaglutide, were associated with better overall outcomes in people with type ...
Microelectronics is currently undergoing major changes: The industry is working on promising new materials and chip ...
A KP astrologer and the world's top economists reach the same conclusion that the recession is unfolding next month, through ...
Dublin-based BeaconSites reports a 14% Perplexity AI citation rate in SurgeGraph's June 2026 benchmark, sevenfold above ...
Trump wants aggressive rate cuts but Fed Chair Kevin Warsh is holding firm at 3.5-3.75% amid 4.2% inflation, creating ...
July 6, 2026 expert reaction to conference abstract from ESHRE on advanced maternal age independently affecting live birth and increasing miscarriage risk in donor oocyte cycles .
Turning off the air conditioner at night to avoid high electricity bills during tropical nights may not benefit your health, ...
Rising energy prices pushed up inflation, crimping the growth outlook for some regions, but not enough to trigger recessions, ...
Traditional therapeutics target the inactive conformation of proteins, allowing tumors to adapt and resume signaling.
Cefazolin demonstrated equivalent survival rates and lower kidney injury risks compared to standard antistaphylococcal ...
HTX Research, the dedicated research arm of HTX, has released its Q3 2026 outlook report, Liquidity Defines Crypto: A New Crypto Order Under Global Liquidity Repricing. Built around two core themes, ...